Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BVA publishes policy position on gene editing
“Whilst recent work has shown its potential benefits, there remain lots of unknowns and more research is needed” – Elizabeth Mullineaux.
Animal health and welfare must come first, position states.

The British Veterinary Association (BVA) has called for gene editing to only be used on animals when it has a demonstrable health or welfare benefit for them.

The stance has been set out in the BVA’s new policy position, Gene Editing of Animals, which has been published in response to the Genetic Technology (Precision Breeding) Act.

The legislation, passed by Parliament last year, allows for gene editing that does not introduce DNA from another organism to be used on plants and animals in commercial agriculture in England. Any DNA changes must theoretically have been able to occur through selective breeding.

Whilst the BVA’s policy position acknowledges that the technology has potential benefits, including improving resistance to disease, it argues that gene editing should not be used as a way to compensate for reduced welfare standards or poor management.

The position also argues that the regulatory framework around gene editing needs to ensure that it is not used to change the appearance of animal for cosmetic reasons or to improve the competitiveness of an animal used in sport.

Elizabeth Mullineaux, BVA president, said: “Gene editing has the potential to be a powerful tool for improving and protecting animal health and welfare.

“However, it must be used responsibly, never for aesthetic reasons or to boost performance in sport. The welfare of any animals involved must also never be compromised.

“Whilst recent work has shown its potential benefits, there remain lots of unknowns and more research is needed. BVA will work closely with the government to help shape this new legislation to ensure that animal health and welfare remains a top priority.”

A talk on gene editing will be held at this year’s BVA Congress on 15 November at 9.30am in the BVA Congress Theatre. The panellists will be Dominic Wells, professor of translational medicine at the Royal Veterinary College, Penny Hawkins, head of the RSPCA’s Animals in Science Department, and Huw Jones, an independent consultant in agri-innovation and animal bioscience.

The full policy position can be read here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Survey launched to investigate EHV

News Story 1
 Zoetis has launched a new survey to identify management techniques for Equine Herpes Virus (EHV).

EHV is a contagious, airborne virus that can cause respiratory problems and severe diseases in horses and ponies. It spreads among horses over short distances, direct contact and through shared equipment.

The survey will explore current knowledge and management practices with EHV in the UK. It is quick to complete and participants could win one of 10 equine first aid kits.

Complete the survey here

Click here for more...
News Shorts
WSAVA launches pet travel guidance factsheet

A new pet travel guidance factsheet for veterinary professionals and caregivers has been developed by the WSAVA in collaboration with the World Veterinary Association.

The Dog and Cat Welfare During Transport factsheet provides step-by-step guidance for all stages of a journey, from pre-travel checklists to post-travel care.

Brachycephalic breeds or animals prone to travel-related anxiety are given special focus in this guide, which also provides links to IATA container regulation and WSAVA vaccination guidelines.